Top Markets
Coin of the day
Regen BioPharma, Inc. Regen BioPharma, Inc.

Regen BioPharma, Inc.

RGBP
Rank in Stocks #42223
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine... Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
Share Price
$0.0001
Market Cap
$3.16K
Change (1 day)
0.00%
Change (1 year)
-99.75%
Country
US
Trade Regen BioPharma, Inc. (RGBP)

Category

Operating Margin for Regen BioPharma, Inc. (RGBP)
Operating Margin as of 2026 TTM: 0.00%
According to Regen BioPharma, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Regen BioPharma, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
31.23% -
BE
0.00% -
KR
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.